Location · Chattanooga, TN
Clinical trials in Chattanooga, TN
41 recruiting studies have a site in Chattanooga, and 2 of them accept healthy volunteers.
41 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteers
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
Femasys Inc.
- Location
- Chattanooga, TN + 11 other US sites
- Eligibility basics
- Ages 21–50 · Women only
- RecruitingHealthy volunteers
Non-Invasive Preeclampsia Screening and Biobank
Sequenom, Inc.
- Location
- Chattanooga, TN + 15 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 2
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
AstraZeneca
- Location
- Chattanooga, TN + 58 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Sanofi
- Location
- Chattanooga, TN + 70 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Location
- Chattanooga, TN + 19 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
CVRx, Inc.
- Location
- Chattanooga, TN + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Biohaven Therapeutics Ltd.
- Location
- Chattanooga, TN + 52 other US sites
- Eligibility basics
- Ages 18–70
- Recruiting
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
Sonavex, Inc.
- Location
- Chattanooga, TN + 19 other US sites
- Eligibility basics
- Ages 18–84
- RecruitingPhase 2
ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
argenx
- Location
- Chattanooga, TN + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Pfizer
- Location
- Chattanooga, TN + 76 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Kardigan, Inc.
- Location
- Chattanooga, TN + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Boehringer Ingelheim
- Location
- Chattanooga, TN + 55 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Boehringer Ingelheim
- Location
- Chattanooga, TN + 56 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Boehringer Ingelheim
- Location
- Chattanooga, TN + 15 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Calico Life Sciences LLC
- Location
- Chattanooga, TN + 33 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 2
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Kymera Therapeutics, Inc.
- Location
- Chattanooga, TN + 30 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Akebia Therapeutics
- Location
- Chattanooga, TN + 28 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Novo Nordisk A/S
- Location
- Chattanooga, TN + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
UCB Biopharma SRL
- Location
- Chattanooga, TN + 41 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
argenx
- Location
- Chattanooga, TN + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
GlaxoSmithKline
- Location
- Chattanooga, TN + 93 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2/Phase 3
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Corxel Pharmaceuticals
- Location
- Chattanooga, TN + 19 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 3
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
GlaxoSmithKline
- Location
- Chattanooga, TN + 46 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Pharmazz, Inc.
- Location
- Chattanooga, TN + 13 other US sites
- Eligibility basics
- Ages 18–80